Your trusted source for investing success

Tag: Aphria Inc.

"Ready to start investing in Cannabis? Get your Investor guide today"

Click below to get an INN Insider's Report on marijuana investing (value of $49) for FREE. Limited time offer. No credit card required.   Get My Free Report Click here to download 

Aphria Announces $50 Million Bought Deal

Aphria (TSXV: APH) (OTCQB: APHQF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 10,000,000 Common Shares (the “Common Shares”)

Aphria Continues Expansion Strategy

Aphria (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.

Aphria Announces $35 Million Bought Deal

Aphria (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 8,750,000 Common Shares (the “Common Shares”) of the

Tetra Bio-Pharma Enters Into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.

Tetra Bio-Pharma (CSE:TBP) through its subsidiary, PhytoPain Pharma Inc., is pleased to announce that it has signed a Supply Agreement with Access to Cannabis for Medical Purpose Regulations (“ACMPR”) licensed producer Aphria Inc. (“Aphria”) (TSX VENTURE:APH)(OTCQB:APHQF) for the supply of dried medical cannabis as an Active Pharmaceutical Ingredient (API) for PPP’s

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

LEAMINGTON, ONTARIO–(Marketwired – Aug. 22, 2016) – Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed a significant cannabis supply agreement with Canadian licenced producer of medical marijuana, Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF).

Cannabis plant species, yields and a novel extraction process have been established in collaboration between Medlab and Aphria,

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network